206 related articles for article (PubMed ID: 35489192)
1. Advanced diffusion imaging to track progression in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Mitchell T; Wilkes BJ; Archer DB; Chu WT; Coombes SA; Lai S; McFarland NR; Okun MS; Black ML; Herschel E; Simuni T; Comella C; Afshari M; Xie T; Li H; Parrish TB; Kurani AS; Corcos DM; Vaillancourt DE
Neuroimage Clin; 2022; 34():103022. PubMed ID: 35489192
[TBL] [Abstract][Full Text] [Related]
2. Free-water imaging in Parkinson's disease and atypical parkinsonism.
Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
[TBL] [Abstract][Full Text] [Related]
3. Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in Parkinsonism.
Mitchell T; Archer DB; Chu WT; Coombes SA; Lai S; Wilkes BJ; McFarland NR; Okun MS; Black ML; Herschel E; Simuni T; Comella C; Xie T; Li H; Parrish TB; Kurani AS; Corcos DM; Vaillancourt DE
Hum Brain Mapp; 2019 Dec; 40(17):5094-5107. PubMed ID: 31403737
[TBL] [Abstract][Full Text] [Related]
4. Free water imaging in Parkinson's disease and atypical parkinsonian disorders.
Shah A; Prasad S; Indoria A; Pal PK; Saini J; Ingalhalikar M
J Neurol; 2024 May; 271(5):2521-2528. PubMed ID: 38265472
[TBL] [Abstract][Full Text] [Related]
5. Regional Selectivity of Neuromelanin Changes in the Substantia Nigra in Atypical Parkinsonism.
Chougar L; Arsovic E; Gaurav R; Biondetti E; Faucher A; Valabrègue R; Pyatigorskaya N; Dupont G; Lejeune FX; Cormier F; Corvol JC; Vidailhet M; Degos B; Grabli D; Lehéricy S
Mov Disord; 2022 Jun; 37(6):1245-1255. PubMed ID: 35347754
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study.
Archer DB; Bricker JT; Chu WT; Burciu RG; McCracken JL; Lai S; Coombes SA; Fang R; Barmpoutis A; Corcos DM; Kurani AS; Mitchell T; Black ML; Herschel E; Simuni T; Parrish TB; Comella C; Xie T; Seppi K; Bohnen NI; Müller ML; Albin RL; Krismer F; Du G; Lewis MM; Huang X; Li H; Pasternak O; McFarland NR; Okun MS; Vaillancourt DE
Lancet Digit Health; 2019 Sep; 1(5):e222-e231. PubMed ID: 33323270
[TBL] [Abstract][Full Text] [Related]
7. Fixel-Based Analysis of White Matter Degeneration in Patients With Progressive Supranuclear Palsy or Multiple System Atrophy, as Compared to Parkinson's Disease.
Nguyen TT; Cheng JS; Chen YL; Lin YC; Tsai CC; Lu CS; Weng YH; Wu YM; Hoang NT; Wang JJ
Front Aging Neurosci; 2021; 13():625874. PubMed ID: 33815089
[No Abstract] [Full Text] [Related]
8. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y
Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391
[TBL] [Abstract][Full Text] [Related]
9. Radiomics on routine T1-weighted MRI can delineate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.
Tupe-Waghmare P; Rajan A; Prasad S; Saini J; Pal PK; Ingalhalikar M
Eur Radiol; 2021 Nov; 31(11):8218-8227. PubMed ID: 33945022
[TBL] [Abstract][Full Text] [Related]
10. Diffusion tensor imaging differentiates vascular parkinsonism from parkinsonian syndromes of degenerative origin in elderly subjects.
Deverdun J; Menjot de Champfleur S; Cabello-Aguilar S; Maury F; Molino F; Charif M; Leboucq N; Ayrignac X; Labauge P; Bonafe A; Castelnovo G; Le Bars E; Geny C; Menjot de Champfleur N
Eur J Radiol; 2014 Nov; 83(11):2074-9. PubMed ID: 25154005
[TBL] [Abstract][Full Text] [Related]
11. Multimodal Magnetic Resonance Imaging Quantification of Brain Changes in Progressive Supranuclear Palsy.
Pyatigorskaya N; Yahia-Cherif L; Gaurav R; Ewenczyk C; Gallea C; Valabregue R; Gargouri F; Magnin B; Degos B; Roze E; Bardinet E; Poupon C; Arnulf I; Vidailhet M; Lehericy S
Mov Disord; 2020 Jan; 35(1):161-170. PubMed ID: 31710146
[TBL] [Abstract][Full Text] [Related]
12. Progression of white matter damage in progressive supranuclear palsy with predominant parkinsonism.
Caso F; Agosta F; Ječmenica-Lukić M; Petrović I; Meani A; Kostic VS; Filippi M
Parkinsonism Relat Disord; 2018 Apr; 49():95-99. PubMed ID: 29336906
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
[TBL] [Abstract][Full Text] [Related]
14. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
15. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.
Tong J; Rathitharan G; Meyer JH; Furukawa Y; Ang LC; Boileau I; Guttman M; Hornykiewicz O; Kish SJ
Brain; 2017 Sep; 140(9):2460-2474. PubMed ID: 29050386
[TBL] [Abstract][Full Text] [Related]
16. Characterization and diagnostic potential of R
Beliveau V; Müller C; Steiger R; Gizewski ER; Poewe W; Seppi K; Scherfler C
Parkinsonism Relat Disord; 2022 Aug; 101():43-48. PubMed ID: 35792337
[TBL] [Abstract][Full Text] [Related]
17. Comparison of mean diffusivity, R2* relaxation rate and morphometric biomarkers for the clinical differentiation of parkinsonism.
Chougar L; Lejeune FX; Faouzi J; Morino B; Faucher A; Hoyek N; Grabli D; Cormier F; Vidailhet M; Corvol JC; Colliot O; Degos B; Lehéricy S
Parkinsonism Relat Disord; 2023 Mar; 108():105287. PubMed ID: 36706616
[TBL] [Abstract][Full Text] [Related]
18. Quantitative susceptibility mapping differentiates between parkinsonian disorders.
Sjöström H; Granberg T; Westman E; Svenningsson P
Parkinsonism Relat Disord; 2017 Nov; 44():51-57. PubMed ID: 28886909
[TBL] [Abstract][Full Text] [Related]
19. Iron deposition in Parkinsonisms: A Quantitative Susceptibility Mapping study in the deep grey matter.
Fedeli MP; Contarino VE; Siggillino S; Samoylova N; Calloni S; Melazzini L; Conte G; Sacilotto G; Pezzoli G; Triulzi FM; Scola E
Eur J Radiol; 2020 Dec; 133():109394. PubMed ID: 33190103
[TBL] [Abstract][Full Text] [Related]
20. Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy.
Neely KA; Planetta PJ; Prodoehl J; Corcos DM; Comella CL; Goetz CG; Shannon KL; Vaillancourt DE
PLoS One; 2013; 8(3):e58403. PubMed ID: 23505500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
